NARA Discovery
Article Details
← Back to Search Results
Journal Article

Activation of MG53 Enhances Cell Survival and Engraftment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Injured Hearts

Ki Ho Park; Xingyu He; Lin Jiang; Hua Zhu; Jialiang Liang; Yigang Wang; Jianjie Ma
Stem Cell Reviews and Reports · Vol. 19, Issue 7 · pp. 2420-2428 · 2023

Abstract

Background and Objective Our previous studies demonstrated that MG53 protein can protect the myocardium, but its use as a therapeutic is challenging due to its short half-life in blood circulation. This study aimed to investigate the cardioprotective role of MG53 on human induced pluripotent stem cell-derived cardiomyocytes (HiPSC-CMs) in the context of myocardial ischemia/reperfusion (I/R). Methods In vitro : HiPSC-CMs were transfected with adenoviral MG53 (HiPSC-CMs MG53 ), in which the expression of MG53 can be controlled by doxycycline (Dox), and the cells were then exposed to H 2 O 2 to mimic ischemia/reperfusion injury. In vivo : HiPSC-CMs MG53 were transplanted into the peri-infarct region in NSG™ mice after I/R. After surgery, mice were treated with Dox (+ Dox) to activate MG53 expression (sucrose as a control of -Dox) and then assessed by echocardiography and immunohistochemistry. Results MG53 can be expressed in HiPSC-CM MG53 and released into the culture medium after adding Dox. The cell survival rate of HiPSC-CM MG53 was improved by Dox under the H 2 O 2 condition. After 14 and 28 days of ischemia/reperfusion (I/R), transplanted HiPSC-CMs MG53 + Dox significantly improved heart function, including ejection fraction (EF) and fractional shortening (FS) in mice, compared to HiPSC-CMs MG53 -Dox, and reduced the size of the infarction. Additionally, HiPSC-CM MG53 + Dox mice demonstrated significant engraftment in the myocardium as shown by staining human nuclei-positive cells. In addition, the cell survival-related AKT signaling was found to be more active in HiPSC-CM MG53 + Dox transplanted mice’s myocardium compared to the HiPSC-CM MG53 -Dox group. Notably, the Dox treatment did not cause harm to other organs. Conclusion Inducible MG53 expression is a promising approach to enhance cell survival and engraftment of HiPSC-CMs for cardiac repair. Graphical Abstract

Bibliographic Information

JournalStem Cell Reviews and Reports
PublisherSpringer
Publication Date2023-10-01
Publication Year2023
Volume19
Issue7
Pages2420-2428
Document TypeJournal Article
Print ISSN2629-3269
eISSN2629-3277
DOI10.1007/s12015-023-10596-0

Access Information

NARA Access Coverage2005-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12015
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.